Literature DB >> 17973363

Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).

Jun Li1, Stephanie Y Chen, James J Li, Haixia Wang, Andres S Hernandez, Shiwei Tao, Christa M Musial, Fucheng Qu, Stephen Swartz, Sam T Chao, Neil Flynn, Brian J Murphy, Dorothy A Slusarchyk, Ramakrishna Seethala, Mujing Yan, Paul Sleph, Gary Grover, Mark A Smith, Blake Beehler, Leah Giupponi, Kenneth E Dickinson, Hongjian Zhang, William G Humphreys, Bharat P Patel, Mark Schwinden, Terry Stouch, Peter T W Cheng, Scott A Biller, William R Ewing, David Gordon, Jeffrey A Robl, Joseph A Tino.   

Abstract

A tetrazole-based peptidomimetic 2 (BMS-317180) was discovered as a human growth hormone secretagogue (GHS). Compound 2 is a potent, novel, orally effective GHS that shows an excellent safety profile in preclinical studies. The compound was advanced into clinical development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973363     DOI: 10.1021/jm7010595

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Synthesis of peptidomimetics, δ- and ε-lactam tetrazoles.

Authors:  Steven Gunawan; Kristen Keck; Alex Laetsch; Christopher Hulme
Journal:  Mol Divers       Date:  2012-05-24       Impact factor: 2.943

Review 2.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

3.  Bifunctional building blocks in the Ugi-azide condensation reaction: a general strategy toward exploration of new molecular diversity.

Authors:  Steven Gunawan; Christopher Hulme
Journal:  Org Biomol Chem       Date:  2013-09-28       Impact factor: 3.876

Review 4.  Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.

Authors:  Gijs Koopmanschap; Eelco Ruijter; Romano Va Orru
Journal:  Beilstein J Org Chem       Date:  2014-03-04       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.